Reitz C L, Bottomley S S
Am J Med Sci. 1984 Jan-Feb;287(1):62-3. doi: 10.1097/00000441-198401000-00020.
A 69-year-old man developed pure red cell aplasia after taking fenoprofen for ten months. The erythroid defect fully reversed after the drug was discontinued and could not be attributed to the patient's previously treated lung carcinoma. This case represents the third example of erythroid aplasia associated with an anti-inflammatory agent and the first instance due to fenoprofen.
一名69岁男性在服用非诺洛芬10个月后出现纯红细胞再生障碍。停药后红细胞生成缺陷完全逆转，且不能归因于该患者先前接受治疗的肺癌。该病例是与一种抗炎药相关的红细胞再生障碍的第三个实例，也是首例由非诺洛芬引起的此类病例。
